SARM inhibits both TRIF- and MyD88-mediated AP-1 activation.
Peng J, Yuan Q, Lin B, Panneerselvam P, Wang X, Luan XL, Lim SK, Leung BP, Ho B, Ding JL.
Peng J, et al. Among authors: yuan q.
Eur J Immunol. 2010 Jun;40(6):1738-47. doi: 10.1002/eji.200940034.
Eur J Immunol. 2010.
PMID: 20306472
Free article.